nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.0788	0.11	CbGbCtD
Valaciclovir—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0703	0.0981	CbGbCtD
Valaciclovir—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0679	0.0948	CbGbCtD
Valaciclovir—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0626	0.0874	CbGbCtD
Valaciclovir—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0605	0.0845	CbGbCtD
Valaciclovir—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0597	0.0834	CbGbCtD
Valaciclovir—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0539	0.0753	CbGbCtD
Valaciclovir—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0515	0.0718	CbGbCtD
Valaciclovir—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0404	0.0563	CbGbCtD
Valaciclovir—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0374	0.0522	CbGbCtD
Valaciclovir—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0348	0.0485	CbGbCtD
Valaciclovir—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0334	0.0466	CbGbCtD
Valaciclovir—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0284	0.0396	CbGbCtD
Valaciclovir—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0192	0.0267	CbGbCtD
Valaciclovir—SLC22A6—Losartan—type 2 diabetes mellitus	0.0175	0.0245	CbGbCtD
Valaciclovir—SLC10A2—nephron tubule—type 2 diabetes mellitus	0.00165	0.161	CbGeAlD
Valaciclovir—SLC10A2—kidney—type 2 diabetes mellitus	0.00145	0.141	CbGeAlD
Valaciclovir—SLC10A2—cortex of kidney—type 2 diabetes mellitus	0.00142	0.137	CbGeAlD
Valaciclovir—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000771	0.0748	CbGeAlD
Valaciclovir—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.00066	0.0641	CbGeAlD
Valaciclovir—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000641	0.0623	CbGeAlD
Valaciclovir—SLC15A1—kidney—type 2 diabetes mellitus	0.000564	0.0547	CbGeAlD
Valaciclovir—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000461	0.0448	CbGeAlD
Valaciclovir—SLC15A2—retina—type 2 diabetes mellitus	0.000426	0.0413	CbGeAlD
Valaciclovir—SLC22A8—kidney—type 2 diabetes mellitus	0.000405	0.0394	CbGeAlD
Valaciclovir—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.000401	0.0389	CbGeAlD
Valaciclovir—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000395	0.0383	CbGeAlD
Valaciclovir—SLC15A1—liver—type 2 diabetes mellitus	0.000356	0.0346	CbGeAlD
Valaciclovir—SLC15A2—kidney—type 2 diabetes mellitus	0.000352	0.0342	CbGeAlD
Valaciclovir—SLC15A2—cortex of kidney—type 2 diabetes mellitus	0.000343	0.0333	CbGeAlD
Valaciclovir—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000132	0.000648	CcSEcCtD
Valaciclovir—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000132	0.000646	CcSEcCtD
Valaciclovir—Pain—Gliclazide—type 2 diabetes mellitus	0.000132	0.000645	CcSEcCtD
Valaciclovir—Constipation—Gliclazide—type 2 diabetes mellitus	0.000132	0.000645	CcSEcCtD
Valaciclovir—Tremor—Losartan—type 2 diabetes mellitus	0.000132	0.000644	CcSEcCtD
Valaciclovir—Rash—Glimepiride—type 2 diabetes mellitus	0.000131	0.000642	CcSEcCtD
Valaciclovir—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000131	0.000642	CcSEcCtD
Valaciclovir—Rash—Sitagliptin—type 2 diabetes mellitus	0.000131	0.00064	CcSEcCtD
Valaciclovir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000131	0.00064	CcSEcCtD
Valaciclovir—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000131	0.00064	CcSEcCtD
Valaciclovir—Headache—Glimepiride—type 2 diabetes mellitus	0.00013	0.000638	CcSEcCtD
Valaciclovir—Cough—Irbesartan—type 2 diabetes mellitus	0.00013	0.000637	CcSEcCtD
Valaciclovir—Headache—Sitagliptin—type 2 diabetes mellitus	0.00013	0.000636	CcSEcCtD
Valaciclovir—Anaemia—Losartan—type 2 diabetes mellitus	0.00013	0.000635	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000129	0.000632	CcSEcCtD
Valaciclovir—Agitation—Losartan—type 2 diabetes mellitus	0.000129	0.000631	CcSEcCtD
Valaciclovir—Oedema—Metformin—type 2 diabetes mellitus	0.000129	0.000631	CcSEcCtD
Valaciclovir—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000129	0.00063	CcSEcCtD
Valaciclovir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000129	0.000629	CcSEcCtD
Valaciclovir—Angioedema—Losartan—type 2 diabetes mellitus	0.000128	0.000628	CcSEcCtD
Valaciclovir—Infection—Metformin—type 2 diabetes mellitus	0.000128	0.000627	CcSEcCtD
Valaciclovir—Insomnia—Valsartan—type 2 diabetes mellitus	0.000128	0.000627	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000128	0.000624	CcSEcCtD
Valaciclovir—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000127	0.000622	CcSEcCtD
Valaciclovir—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000127	0.000622	CcSEcCtD
Valaciclovir—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000127	0.000621	CcSEcCtD
Valaciclovir—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000127	0.000621	CcSEcCtD
Valaciclovir—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000127	0.000621	CcSEcCtD
Valaciclovir—Insomnia—Orlistat—type 2 diabetes mellitus	0.000127	0.000619	CcSEcCtD
Valaciclovir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000127	0.000619	CcSEcCtD
Valaciclovir—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000127	0.000619	CcSEcCtD
Valaciclovir—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000126	0.000618	CcSEcCtD
Valaciclovir—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000126	0.000618	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000126	0.000617	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000126	0.000617	CcSEcCtD
Valaciclovir—Somnolence—Valsartan—type 2 diabetes mellitus	0.000126	0.000616	CcSEcCtD
Valaciclovir—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000126	0.000615	CcSEcCtD
Valaciclovir—Leukopenia—Losartan—type 2 diabetes mellitus	0.000126	0.000615	CcSEcCtD
Valaciclovir—Skin disorder—Metformin—type 2 diabetes mellitus	0.000125	0.000613	CcSEcCtD
Valaciclovir—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000125	0.000611	CcSEcCtD
Valaciclovir—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000125	0.00061	CcSEcCtD
Valaciclovir—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000125	0.00061	CcSEcCtD
Valaciclovir—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000124	0.000608	CcSEcCtD
Valaciclovir—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000124	0.000608	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000124	0.0018	CbGpPWpGaD
Valaciclovir—Nausea—Glimepiride—type 2 diabetes mellitus	0.000124	0.000605	CcSEcCtD
Valaciclovir—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000123	0.000603	CcSEcCtD
Valaciclovir—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000123	0.000603	CcSEcCtD
Valaciclovir—Asthenia—Glyburide—type 2 diabetes mellitus	0.000123	0.000603	CcSEcCtD
Valaciclovir—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000123	0.000603	CcSEcCtD
Valaciclovir—Anorexia—Metformin—type 2 diabetes mellitus	0.000123	0.000602	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYTB—type 2 diabetes mellitus	0.000123	0.00178	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—OXCT1—type 2 diabetes mellitus	0.000123	0.00178	CbGpPWpGaD
Valaciclovir—Cough—Losartan—type 2 diabetes mellitus	0.000122	0.000599	CcSEcCtD
Valaciclovir—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000122	0.000599	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000122	0.000598	CcSEcCtD
Valaciclovir—Alopecia—Ramipril—type 2 diabetes mellitus	0.000122	0.000598	CcSEcCtD
Valaciclovir—Fatigue—Valsartan—type 2 diabetes mellitus	0.000122	0.000598	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000122	0.00177	CbGpPWpGaD
Valaciclovir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000122	0.000596	CcSEcCtD
Valaciclovir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000122	0.000596	CcSEcCtD
Valaciclovir—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000122	0.000596	CcSEcCtD
Valaciclovir—Oedema—Irbesartan—type 2 diabetes mellitus	0.000122	0.000596	CcSEcCtD
Valaciclovir—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000122	0.000595	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000121	0.00176	CbGpPWpGaD
Valaciclovir—Pruritus—Glyburide—type 2 diabetes mellitus	0.000121	0.000594	CcSEcCtD
Valaciclovir—Constipation—Valsartan—type 2 diabetes mellitus	0.000121	0.000593	CcSEcCtD
Valaciclovir—Infection—Irbesartan—type 2 diabetes mellitus	0.000121	0.000592	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000121	0.000591	CcSEcCtD
Valaciclovir—Fatigue—Orlistat—type 2 diabetes mellitus	0.000121	0.000591	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—SRD5A1—type 2 diabetes mellitus	0.00012	0.00174	CbGpPWpGaD
Valaciclovir—Pain—Orlistat—type 2 diabetes mellitus	0.00012	0.000586	CcSEcCtD
Valaciclovir—Chest pain—Losartan—type 2 diabetes mellitus	0.00012	0.000585	CcSEcCtD
Valaciclovir—Arthralgia—Losartan—type 2 diabetes mellitus	0.00012	0.000585	CcSEcCtD
Valaciclovir—Myalgia—Losartan—type 2 diabetes mellitus	0.00012	0.000585	CcSEcCtD
Valaciclovir—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000119	0.000584	CcSEcCtD
Valaciclovir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000119	0.000584	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000119	0.00173	CbGpPWpGaD
Valaciclovir—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000119	0.000583	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000119	0.00173	CbGpPWpGaD
Valaciclovir—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000119	0.000581	CcSEcCtD
Valaciclovir—Rash—Bromocriptine—type 2 diabetes mellitus	0.000118	0.00058	CcSEcCtD
Valaciclovir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000579	CcSEcCtD
Valaciclovir—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000118	0.000579	CcSEcCtD
Valaciclovir—Tension—Ramipril—type 2 diabetes mellitus	0.000118	0.000578	CcSEcCtD
Valaciclovir—Headache—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000576	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000118	0.000575	CcSEcCtD
Valaciclovir—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000117	0.000575	CcSEcCtD
Valaciclovir—Nervousness—Ramipril—type 2 diabetes mellitus	0.000117	0.000572	CcSEcCtD
Valaciclovir—Dry mouth—Losartan—type 2 diabetes mellitus	0.000117	0.000572	CcSEcCtD
Valaciclovir—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000116	0.000568	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000116	0.00168	CbGpPWpGaD
Valaciclovir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000116	0.000567	CcSEcCtD
Valaciclovir—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000116	0.000567	CcSEcCtD
Valaciclovir—Confusional state—Losartan—type 2 diabetes mellitus	0.000116	0.000565	CcSEcCtD
Valaciclovir—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000115	0.000564	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000115	0.00167	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000115	0.00167	CbGpPWpGaD
Valaciclovir—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000115	0.000563	CcSEcCtD
Valaciclovir—Somnolence—Metformin—type 2 diabetes mellitus	0.000115	0.000561	CcSEcCtD
Valaciclovir—Oedema—Losartan—type 2 diabetes mellitus	0.000115	0.000561	CcSEcCtD
Valaciclovir—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000115	0.000561	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000114	0.00056	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000114	0.00166	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ACACA—type 2 diabetes mellitus	0.000114	0.00166	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—STAR—type 2 diabetes mellitus	0.000114	0.00166	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000114	0.00166	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000114	0.00166	CbGpPWpGaD
Valaciclovir—Infection—Losartan—type 2 diabetes mellitus	0.000114	0.000557	CcSEcCtD
Valaciclovir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000114	0.000556	CcSEcCtD
Valaciclovir—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000114	0.000556	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000113	0.00164	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000113	0.00164	CbGpPWpGaD
Valaciclovir—Tremor—Ramipril—type 2 diabetes mellitus	0.000113	0.000552	CcSEcCtD
Valaciclovir—Urticaria—Valsartan—type 2 diabetes mellitus	0.000113	0.000551	CcSEcCtD
Valaciclovir—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000112	0.00055	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000112	0.00163	CbGpPWpGaD
Valaciclovir—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000112	0.000549	CcSEcCtD
Valaciclovir—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000112	0.000549	CcSEcCtD
Valaciclovir—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000112	0.000548	CcSEcCtD
Valaciclovir—Tachycardia—Losartan—type 2 diabetes mellitus	0.000112	0.000547	CcSEcCtD
Valaciclovir—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000546	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000111	0.000545	CcSEcCtD
Valaciclovir—Fatigue—Metformin—type 2 diabetes mellitus	0.000111	0.000544	CcSEcCtD
Valaciclovir—Urticaria—Orlistat—type 2 diabetes mellitus	0.000111	0.000544	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000111	0.000543	CcSEcCtD
Valaciclovir—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000111	0.000541	CcSEcCtD
Valaciclovir—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000111	0.000541	CcSEcCtD
Valaciclovir—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000111	0.000541	CcSEcCtD
Valaciclovir—Agitation—Ramipril—type 2 diabetes mellitus	0.000111	0.000541	CcSEcCtD
Valaciclovir—Constipation—Metformin—type 2 diabetes mellitus	0.00011	0.00054	CcSEcCtD
Valaciclovir—Angioedema—Ramipril—type 2 diabetes mellitus	0.00011	0.000538	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ABCC8—type 2 diabetes mellitus	0.00011	0.00159	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CBS—type 2 diabetes mellitus	0.00011	0.00159	CbGpPWpGaD
Valaciclovir—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000109	0.000535	CcSEcCtD
Valaciclovir—Anorexia—Losartan—type 2 diabetes mellitus	0.000109	0.000534	CcSEcCtD
Valaciclovir—Vomiting—Glyburide—type 2 diabetes mellitus	0.000109	0.000534	CcSEcCtD
Valaciclovir—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000109	0.000534	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000109	0.00158	CbGpPWpGaD
Valaciclovir—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000109	0.000531	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000108	0.00157	CbGpPWpGaD
Valaciclovir—Rash—Glyburide—type 2 diabetes mellitus	0.000108	0.00053	CcSEcCtD
Valaciclovir—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000108	0.00053	CcSEcCtD
Valaciclovir—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000108	0.000529	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000108	0.00157	CbGpPWpGaD
Valaciclovir—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000108	0.000527	CcSEcCtD
Valaciclovir—Headache—Glyburide—type 2 diabetes mellitus	0.000108	0.000526	CcSEcCtD
Valaciclovir—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000107	0.000524	CcSEcCtD
Valaciclovir—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000106	0.00052	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—TGFB1—type 2 diabetes mellitus	0.000106	0.00154	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000106	0.00154	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	0.000106	0.00153	CbGpPWpGaD
Valaciclovir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000106	0.000518	CcSEcCtD
Valaciclovir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000105	0.000516	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000105	0.000516	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000105	0.00153	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—COX2—type 2 diabetes mellitus	0.000105	0.00153	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000105	0.00153	CbGpPWpGaD
Valaciclovir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000105	0.000514	CcSEcCtD
Valaciclovir—Cough—Ramipril—type 2 diabetes mellitus	0.000105	0.000514	CcSEcCtD
Valaciclovir—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000105	0.000514	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000104	0.00151	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000104	0.000511	CcSEcCtD
Valaciclovir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000104	0.000511	CcSEcCtD
Valaciclovir—Convulsion—Ramipril—type 2 diabetes mellitus	0.000104	0.00051	CcSEcCtD
Valaciclovir—Pain—Irbesartan—type 2 diabetes mellitus	0.000104	0.000509	CcSEcCtD
Valaciclovir—Constipation—Irbesartan—type 2 diabetes mellitus	0.000104	0.000509	CcSEcCtD
Valaciclovir—Insomnia—Losartan—type 2 diabetes mellitus	0.000104	0.000507	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—NCOA6—type 2 diabetes mellitus	0.000104	0.0015	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000103	0.0015	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000103	0.0015	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000103	0.000505	CcSEcCtD
Valaciclovir—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000103	0.000503	CcSEcCtD
Valaciclovir—Urticaria—Metformin—type 2 diabetes mellitus	0.000102	0.000501	CcSEcCtD
Valaciclovir—Myalgia—Ramipril—type 2 diabetes mellitus	0.000102	0.000501	CcSEcCtD
Valaciclovir—Chest pain—Ramipril—type 2 diabetes mellitus	0.000102	0.000501	CcSEcCtD
Valaciclovir—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000102	0.000501	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000102	0.00148	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000102	0.00148	CbGpPWpGaD
Valaciclovir—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000102	0.0005	CcSEcCtD
Valaciclovir—Nausea—Glyburide—type 2 diabetes mellitus	0.000102	0.000499	CcSEcCtD
Valaciclovir—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000102	0.000499	CcSEcCtD
Valaciclovir—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000102	0.000499	CcSEcCtD
Valaciclovir—Somnolence—Losartan—type 2 diabetes mellitus	0.000102	0.000498	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000102	0.00148	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—UCP3—type 2 diabetes mellitus	0.000102	0.00148	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—UCP2—type 2 diabetes mellitus	0.000102	0.00148	CbGpPWpGaD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000102	0.000498	CcSEcCtD
Valaciclovir—Asthenia—Valsartan—type 2 diabetes mellitus	0.000102	0.000497	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000101	0.00147	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000101	0.00147	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000101	0.00147	CbGpPWpGaD
Valaciclovir—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000101	0.000493	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000101	0.00146	CbGpPWpGaD
Valaciclovir—Asthenia—Orlistat—type 2 diabetes mellitus	0.0001	0.000491	CcSEcCtD
Valaciclovir—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.0001	0.000491	CcSEcCtD
Valaciclovir—Pruritus—Valsartan—type 2 diabetes mellitus	0.0001	0.00049	CcSEcCtD
Valaciclovir—Dry mouth—Ramipril—type 2 diabetes mellitus	0.0001	0.00049	CcSEcCtD
Valaciclovir—Decreased appetite—Losartan—type 2 diabetes mellitus	9.96e-05	0.000487	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.95e-05	0.000487	CcSEcCtD
Valaciclovir—Confusional state—Ramipril—type 2 diabetes mellitus	9.9e-05	0.000485	CcSEcCtD
Valaciclovir—Pruritus—Orlistat—type 2 diabetes mellitus	9.9e-05	0.000485	CcSEcCtD
Valaciclovir—Fatigue—Losartan—type 2 diabetes mellitus	9.88e-05	0.000483	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	9.87e-05	0.00143	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.84e-05	0.00143	CbGpPWpGaD
Valaciclovir—Oedema—Ramipril—type 2 diabetes mellitus	9.82e-05	0.000481	CcSEcCtD
Valaciclovir—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.82e-05	0.000481	CcSEcCtD
Valaciclovir—Vomiting—Gliclazide—type 2 diabetes mellitus	9.8e-05	0.00048	CcSEcCtD
Valaciclovir—Constipation—Losartan—type 2 diabetes mellitus	9.8e-05	0.000479	CcSEcCtD
Valaciclovir—Pain—Losartan—type 2 diabetes mellitus	9.8e-05	0.000479	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.8e-05	0.00142	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	9.74e-05	0.00141	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	9.74e-05	0.00141	CbGpPWpGaD
Valaciclovir—Rash—Gliclazide—type 2 diabetes mellitus	9.72e-05	0.000476	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	9.72e-05	0.00141	CbGpPWpGaD
Valaciclovir—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.71e-05	0.000475	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.71e-05	0.00141	CbGpPWpGaD
Valaciclovir—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.69e-05	0.000474	CcSEcCtD
Valaciclovir—Urticaria—Irbesartan—type 2 diabetes mellitus	9.67e-05	0.000473	CcSEcCtD
Valaciclovir—Headache—Gliclazide—type 2 diabetes mellitus	9.66e-05	0.000473	CcSEcCtD
Valaciclovir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.63e-05	0.000471	CcSEcCtD
Valaciclovir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.62e-05	0.000471	CcSEcCtD
Valaciclovir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.62e-05	0.000471	CcSEcCtD
Valaciclovir—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000471	CcSEcCtD
Valaciclovir—Tachycardia—Ramipril—type 2 diabetes mellitus	9.59e-05	0.000469	CcSEcCtD
Valaciclovir—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.58e-05	0.000469	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PCK1—type 2 diabetes mellitus	9.57e-05	0.00139	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	9.56e-05	0.00139	CbGpPWpGaD
Valaciclovir—Skin disorder—Ramipril—type 2 diabetes mellitus	9.54e-05	0.000467	CcSEcCtD
Valaciclovir—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.44e-05	0.000462	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	9.42e-05	0.00137	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	9.41e-05	0.00136	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	9.39e-05	0.00136	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	9.39e-05	0.00136	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.38e-05	0.00136	CbGpPWpGaD
Valaciclovir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.37e-05	0.000458	CcSEcCtD
Valaciclovir—Dizziness—Valsartan—type 2 diabetes mellitus	9.37e-05	0.000458	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	9.37e-05	0.00136	CbGpPWpGaD
Valaciclovir—Anorexia—Ramipril—type 2 diabetes mellitus	9.36e-05	0.000458	CcSEcCtD
Valaciclovir—Dizziness—Orlistat—type 2 diabetes mellitus	9.26e-05	0.000453	CcSEcCtD
Valaciclovir—Asthenia—Metformin—type 2 diabetes mellitus	9.25e-05	0.000453	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	9.19e-05	0.00133	CbGpPWpGaD
Valaciclovir—Nausea—Gliclazide—type 2 diabetes mellitus	9.16e-05	0.000448	CcSEcCtD
Valaciclovir—Pruritus—Metformin—type 2 diabetes mellitus	9.13e-05	0.000447	CcSEcCtD
Valaciclovir—Urticaria—Losartan—type 2 diabetes mellitus	9.1e-05	0.000445	CcSEcCtD
Valaciclovir—Body temperature increased—Losartan—type 2 diabetes mellitus	9.06e-05	0.000443	CcSEcCtD
Valaciclovir—Abdominal pain—Losartan—type 2 diabetes mellitus	9.06e-05	0.000443	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	9.04e-05	0.00131	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	9.04e-05	0.00131	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	9.02e-05	0.00131	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	9.02e-05	0.00131	CbGpPWpGaD
Valaciclovir—Vomiting—Valsartan—type 2 diabetes mellitus	9.01e-05	0.000441	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9e-05	0.0013	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.97e-05	0.000439	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—HK1—type 2 diabetes mellitus	8.96e-05	0.0013	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	8.96e-05	0.0013	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	8.95e-05	0.0013	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.95e-05	0.000438	CcSEcCtD
Valaciclovir—Rash—Valsartan—type 2 diabetes mellitus	8.93e-05	0.000437	CcSEcCtD
Valaciclovir—Dermatitis—Valsartan—type 2 diabetes mellitus	8.92e-05	0.000437	CcSEcCtD
Valaciclovir—Vomiting—Orlistat—type 2 diabetes mellitus	8.9e-05	0.000435	CcSEcCtD
Valaciclovir—Insomnia—Ramipril—type 2 diabetes mellitus	8.88e-05	0.000435	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	8.88e-05	0.00129	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	8.88e-05	0.00129	CbGpPWpGaD
Valaciclovir—Headache—Valsartan—type 2 diabetes mellitus	8.87e-05	0.000434	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	8.85e-05	0.00128	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	8.84e-05	0.00128	CbGpPWpGaD
Valaciclovir—Diarrhoea—Metformin—type 2 diabetes mellitus	8.83e-05	0.000432	CcSEcCtD
Valaciclovir—Rash—Orlistat—type 2 diabetes mellitus	8.83e-05	0.000432	CcSEcCtD
Valaciclovir—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.82e-05	0.000432	CcSEcCtD
Valaciclovir—Dermatitis—Orlistat—type 2 diabetes mellitus	8.82e-05	0.000431	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.77e-05	0.00127	CbGpPWpGaD
Valaciclovir—Headache—Orlistat—type 2 diabetes mellitus	8.77e-05	0.000429	CcSEcCtD
Valaciclovir—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.76e-05	0.000429	CcSEcCtD
Valaciclovir—Asthenia—Irbesartan—type 2 diabetes mellitus	8.73e-05	0.000427	CcSEcCtD
Valaciclovir—Somnolence—Ramipril—type 2 diabetes mellitus	8.73e-05	0.000427	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—KCNJ11—type 2 diabetes mellitus	8.66e-05	0.00125	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GCKR—type 2 diabetes mellitus	8.66e-05	0.00125	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HSD3B2—type 2 diabetes mellitus	8.66e-05	0.00125	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LPA—type 2 diabetes mellitus	8.66e-05	0.00125	CbGpPWpGaD
Valaciclovir—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000423	CcSEcCtD
Valaciclovir—Pruritus—Irbesartan—type 2 diabetes mellitus	8.61e-05	0.000421	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	8.61e-05	0.00125	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.58e-05	0.00124	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	8.55e-05	0.00124	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	8.55e-05	0.00124	CbGpPWpGaD
Valaciclovir—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000418	CcSEcCtD
Valaciclovir—Dizziness—Metformin—type 2 diabetes mellitus	8.53e-05	0.000417	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.48e-05	0.000415	CcSEcCtD
Valaciclovir—Fatigue—Ramipril—type 2 diabetes mellitus	8.47e-05	0.000414	CcSEcCtD
Valaciclovir—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.44e-05	0.000413	CcSEcCtD
Valaciclovir—Nausea—Valsartan—type 2 diabetes mellitus	8.41e-05	0.000412	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	8.4e-05	0.00122	CbGpPWpGaD
Valaciclovir—Constipation—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000411	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	8.37e-05	0.00121	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	8.35e-05	0.00121	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	8.35e-05	0.00121	CbGpPWpGaD
Valaciclovir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.33e-05	0.000408	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.32e-05	0.00121	CbGpPWpGaD
Valaciclovir—Nausea—Orlistat—type 2 diabetes mellitus	8.31e-05	0.000407	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ALDOB—type 2 diabetes mellitus	8.3e-05	0.0012	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	8.28e-05	0.0012	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	8.26e-05	0.0012	CbGpPWpGaD
Valaciclovir—Asthenia—Losartan—type 2 diabetes mellitus	8.22e-05	0.000402	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	8.2e-05	0.00119	CbGpPWpGaD
Valaciclovir—Vomiting—Metformin—type 2 diabetes mellitus	8.2e-05	0.000401	CcSEcCtD
Valaciclovir—Rash—Metformin—type 2 diabetes mellitus	8.13e-05	0.000398	CcSEcCtD
Valaciclovir—Dermatitis—Metformin—type 2 diabetes mellitus	8.13e-05	0.000398	CcSEcCtD
Valaciclovir—Pruritus—Losartan—type 2 diabetes mellitus	8.11e-05	0.000397	CcSEcCtD
Valaciclovir—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.09e-05	0.000396	CcSEcCtD
Valaciclovir—Headache—Metformin—type 2 diabetes mellitus	8.08e-05	0.000395	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.06e-05	0.00117	CbGpPWpGaD
Valaciclovir—Dizziness—Irbesartan—type 2 diabetes mellitus	8.05e-05	0.000394	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	8.04e-05	0.00116	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	8.04e-05	0.00116	CbGpPWpGaD
Valaciclovir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.03e-05	0.000393	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	8.02e-05	0.00116	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.02e-05	0.00116	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	7.99e-05	0.00116	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.91e-05	0.00115	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.9e-05	0.00114	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	7.89e-05	0.00114	CbGpPWpGaD
Valaciclovir—Diarrhoea—Losartan—type 2 diabetes mellitus	7.84e-05	0.000384	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	7.82e-05	0.00113	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.81e-05	0.00113	CbGpPWpGaD
Valaciclovir—Urticaria—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000382	CcSEcCtD
Valaciclovir—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.77e-05	0.00038	CcSEcCtD
Valaciclovir—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.77e-05	0.00038	CcSEcCtD
Valaciclovir—Vomiting—Irbesartan—type 2 diabetes mellitus	7.74e-05	0.000379	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GLP1R—type 2 diabetes mellitus	7.72e-05	0.00112	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	7.68e-05	0.00111	CbGpPWpGaD
Valaciclovir—Rash—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.000376	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	7.67e-05	0.00111	CbGpPWpGaD
Valaciclovir—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.67e-05	0.000375	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	7.66e-05	0.00111	CbGpPWpGaD
Valaciclovir—Nausea—Metformin—type 2 diabetes mellitus	7.66e-05	0.000375	CcSEcCtD
Valaciclovir—Headache—Irbesartan—type 2 diabetes mellitus	7.63e-05	0.000373	CcSEcCtD
Valaciclovir—Dizziness—Losartan—type 2 diabetes mellitus	7.58e-05	0.000371	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.42e-05	0.00108	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	7.42e-05	0.00108	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	7.3e-05	0.00106	CbGpPWpGaD
Valaciclovir—Vomiting—Losartan—type 2 diabetes mellitus	7.28e-05	0.000356	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.24e-05	0.00105	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.24e-05	0.000354	CcSEcCtD
Valaciclovir—Nausea—Irbesartan—type 2 diabetes mellitus	7.23e-05	0.000354	CcSEcCtD
Valaciclovir—Rash—Losartan—type 2 diabetes mellitus	7.22e-05	0.000353	CcSEcCtD
Valaciclovir—Dermatitis—Losartan—type 2 diabetes mellitus	7.22e-05	0.000353	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—SLC2A2—type 2 diabetes mellitus	7.2e-05	0.00104	CbGpPWpGaD
Valaciclovir—Headache—Losartan—type 2 diabetes mellitus	7.18e-05	0.000351	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	7.11e-05	0.00103	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MTR—type 2 diabetes mellitus	7.06e-05	0.00102	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CPT1A—type 2 diabetes mellitus	7.06e-05	0.00102	CbGpPWpGaD
Valaciclovir—Asthenia—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000345	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	6.98e-05	0.00101	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	6.97e-05	0.00101	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	6.97e-05	0.00101	CbGpPWpGaD
Valaciclovir—Pruritus—Ramipril—type 2 diabetes mellitus	6.95e-05	0.00034	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—NAMPT—type 2 diabetes mellitus	6.92e-05	0.001	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.88e-05	0.000997	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LIPC—type 2 diabetes mellitus	6.88e-05	0.000997	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HBA1—type 2 diabetes mellitus	6.88e-05	0.000997	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GCK—type 2 diabetes mellitus	6.88e-05	0.000997	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP11A1—type 2 diabetes mellitus	6.83e-05	0.000991	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	6.83e-05	0.00099	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	6.82e-05	0.000989	CbGpPWpGaD
Valaciclovir—Nausea—Losartan—type 2 diabetes mellitus	6.8e-05	0.000333	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.79e-05	0.000984	CbGpPWpGaD
Valaciclovir—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.72e-05	0.000329	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—SLC9A1—type 2 diabetes mellitus	6.71e-05	0.000973	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	6.71e-05	0.000972	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	6.71e-05	0.000972	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	6.7e-05	0.000971	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	6.65e-05	0.000964	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CETP—type 2 diabetes mellitus	6.63e-05	0.000962	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	6.6e-05	0.000957	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	6.59e-05	0.000955	CbGpPWpGaD
Valaciclovir—Dizziness—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000318	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	6.35e-05	0.000921	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	6.35e-05	0.000921	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	6.33e-05	0.000917	CbGpPWpGaD
Valaciclovir—Vomiting—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000306	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	6.2e-05	0.000899	CbGpPWpGaD
Valaciclovir—Rash—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000303	CcSEcCtD
Valaciclovir—Dermatitis—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000303	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.19e-05	0.000897	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	6.17e-05	0.000895	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PSMD6—type 2 diabetes mellitus	6.17e-05	0.000894	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SNAP25—type 2 diabetes mellitus	6.17e-05	0.000894	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SREBF1—type 2 diabetes mellitus	6.17e-05	0.000894	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	6.16e-05	0.000893	CbGpPWpGaD
Valaciclovir—Headache—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000301	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	6.13e-05	0.000888	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	6.09e-05	0.000883	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CTGF—type 2 diabetes mellitus	6.05e-05	0.000878	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HMGCR—type 2 diabetes mellitus	6e-05	0.00087	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.92e-05	0.000858	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	5.89e-05	0.000854	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	5.89e-05	0.000854	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.88e-05	0.000853	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ADRA2A—type 2 diabetes mellitus	5.87e-05	0.000851	CbGpPWpGaD
Valaciclovir—Nausea—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000286	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	5.75e-05	0.000834	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	5.72e-05	0.000829	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	5.7e-05	0.000827	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	5.69e-05	0.000825	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	5.69e-05	0.000824	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP2E1—type 2 diabetes mellitus	5.64e-05	0.000818	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC2A1—type 2 diabetes mellitus	5.58e-05	0.000809	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP1A2—type 2 diabetes mellitus	5.58e-05	0.000809	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	5.51e-05	0.000798	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	5.49e-05	0.000796	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP3A4—type 2 diabetes mellitus	5.44e-05	0.000788	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.41e-05	0.000784	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.4e-05	0.000783	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.38e-05	0.00078	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GCG—type 2 diabetes mellitus	5.35e-05	0.000775	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC2A4—type 2 diabetes mellitus	5.35e-05	0.000775	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	5.28e-05	0.000765	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	5.24e-05	0.00076	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	5.24e-05	0.00076	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.15e-05	0.000747	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	5.12e-05	0.000742	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	5.09e-05	0.000737	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	5.06e-05	0.000733	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.01e-05	0.000727	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	5.01e-05	0.000726	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.94e-05	0.000716	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.78e-05	0.000693	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	4.65e-05	0.000674	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GNB3—type 2 diabetes mellitus	4.61e-05	0.000668	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.61e-05	0.000668	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.59e-05	0.000665	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.58e-05	0.000664	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.58e-05	0.000664	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CAT—type 2 diabetes mellitus	4.53e-05	0.000656	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.46e-05	0.000646	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APOB—type 2 diabetes mellitus	4.39e-05	0.000637	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.38e-05	0.000634	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.38e-05	0.000634	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.28e-05	0.00062	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.27e-05	0.000619	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.26e-05	0.000617	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.25e-05	0.000616	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.25e-05	0.000615	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.24e-05	0.000614	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.22e-05	0.000612	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.2e-05	0.000609	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LPL—type 2 diabetes mellitus	4.2e-05	0.000608	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	4.13e-05	0.000599	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.11e-05	0.000596	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GPX1—type 2 diabetes mellitus	4.09e-05	0.000593	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.08e-05	0.000591	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.06e-05	0.000588	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CD36—type 2 diabetes mellitus	3.99e-05	0.000578	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.95e-05	0.000573	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.94e-05	0.000571	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.93e-05	0.00057	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.9e-05	0.000565	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.79e-05	0.00055	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.78e-05	0.000548	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.77e-05	0.000546	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.72e-05	0.000539	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPARA—type 2 diabetes mellitus	3.71e-05	0.000537	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AGT—type 2 diabetes mellitus	3.59e-05	0.00052	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.55e-05	0.000514	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CALM1—type 2 diabetes mellitus	3.53e-05	0.000512	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.52e-05	0.00051	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APOE—type 2 diabetes mellitus	3.52e-05	0.00051	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.51e-05	0.000509	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.5e-05	0.000507	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APOA1—type 2 diabetes mellitus	3.48e-05	0.000504	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.47e-05	0.000503	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	3.45e-05	0.0005	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.42e-05	0.000496	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.4e-05	0.000493	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.35e-05	0.000486	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.21e-05	0.000466	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.18e-05	0.000461	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.13e-05	0.000454	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPARG—type 2 diabetes mellitus	3.06e-05	0.000444	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—INS—type 2 diabetes mellitus	3.01e-05	0.000436	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.98e-05	0.000432	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.93e-05	0.000425	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.92e-05	0.000423	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.89e-05	0.000419	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.83e-05	0.00041	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.8e-05	0.000405	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALB—type 2 diabetes mellitus	2.75e-05	0.000399	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.65e-05	0.000384	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.64e-05	0.000382	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NOS3—type 2 diabetes mellitus	2.64e-05	0.000382	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.61e-05	0.000379	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.54e-05	0.000369	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.41e-05	0.000349	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.36e-05	0.000342	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.36e-05	0.000342	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.21e-05	0.000321	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.1e-05	0.000304	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.75e-05	0.000254	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AKT1—type 2 diabetes mellitus	1.21e-05	0.000176	CbGpPWpGaD
